Suppr超能文献

[扁桃体切除术联合类固醇冲击疗法成功治疗过敏性紫癜性肾炎病例]

[Case of Henoch-Schönlein purpura nephritis successfully treated with tonsillectomy and steroid pulse therapy].

作者信息

Iwamoto Mari, Wakabayashi Mai, Hanada Shigeru, Kobayashi Namiko, Hata Toshihiko, Ando Ryoichi

机构信息

Department of Nephrology, Musashino Red Cross Hospital, Tokyo, Japan.

出版信息

Nihon Jinzo Gakkai Shi. 2009;51(4):484-9.

Abstract

A 30-year-old Japanese man was admitted to our hospital because of fever, sore throat, abdominal pain, purpura skin lesion of the lower legs, and macrohematuria. On admission, his urine was positive (++) for protein; the sediment contained 100 red blood cells per high-power field, and the daily proteinuria level was 1.7 g. Renal biopsy was performed, and we diagnosed Henoch-Schönlein purpura nephritis (HSPN). Six months after the renal biopsy, the patient underwent a tonsillectomy. The pathological diagnosis of the resected tonsils was chronic tonsillitis. After tonsillectomy, the daily proteinuria had decreased to 0.1 g and the sediment contained only 10-19 red blood cells per high-power field. High-dose methylprednisolone therapy (500 mg/day for 3 days for three courses) was started two weeks after the tonsillectomy, followed by oral prednisolone at the initial dose of 30 mg on alternate days. The oral prednisolone was tapered gradually over 1 year. Antiplatelet drug (dipyridamole, 300 mg/day) and angiotensin II receptor antagonist (olmesartan, 10 mg/day) were also administered. This combination therapy resulted in a significant decrease in proteinuria and disappearance of microhematuria. The patient finally achieved clinical remission. Recent reports have shown that in patients with IgA nephropathy, combined tonsillectomy and methylprednisolone pulse therapy have an effect on clinical remission. In addition, it has been suggested that HSPN and IgA nephropathy represent a spectrum of clinical presentations of similar disorders. The result of this case indicated that this combination therapy had a favorable effect on clinical remission in adult patients with HSPN.

摘要

一名30岁的日本男性因发热、咽痛、腹痛、小腿紫癜性皮肤病变及肉眼血尿入住我院。入院时,他的尿液蛋白呈阳性(++);尿沉渣每高倍视野含100个红细胞,每日蛋白尿水平为1.7g。进行了肾活检,诊断为过敏性紫癜性肾炎(HSPN)。肾活检6个月后,患者接受了扁桃体切除术。切除扁桃体的病理诊断为慢性扁桃体炎。扁桃体切除术后,每日蛋白尿降至0.1g,尿沉渣每高倍视野仅含10 - 19个红细胞。扁桃体切除术后两周开始大剂量甲泼尼龙治疗(500mg/天,共3天,共三个疗程),随后口服泼尼松龙,初始剂量为30mg隔日一次。口服泼尼松龙在1年内逐渐减量。还给予了抗血小板药物(双嘧达莫,300mg/天)和血管紧张素II受体拮抗剂(奥美沙坦,10mg/天)。这种联合治疗导致蛋白尿显著减少,镜下血尿消失。患者最终实现临床缓解。最近的报告显示,在IgA肾病患者中,联合扁桃体切除术和甲泼尼龙冲击疗法对临床缓解有效果。此外,有人提出HSPN和IgA肾病代表了一系列相似疾病的临床表现。该病例的结果表明,这种联合治疗对成年HSPN患者的临床缓解有良好效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验